PCI Biotech Holding ASA (PCIB.OL)
NOK 1.42
(-1.39%)
NOK 1.42
(-1.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.97 Million | -59.04 Million | -68.3 Million | -77.39 Million | -83.47 Million | -31.07 Million |
| Net Income | -20.31 Million | -55.09 Million | -88.39 Million | -72.23 Million | -88.74 Million | -34.78 Million |
| Depreciation & Amortization | 371 Thousand | 6.4 Million | 2.54 Million | 2.2 Million | 955 Thousand | 5000.00 |
| Deferred income taxes | - | - | 2.52 Million | -8.52 Million | -126 Thousand | -1000.00 |
| Stock-based compensation | 1.95 Million | -1.29 Million | 12.93 Million | 6.33 Million | 2.43 Million | 4.05 Million |
| Change in working capital | 2.97 Million | -8.93 Million | 2.03 Million | -5.24 Million | 1.97 Million | 420 Thousand |
| Other non-cash items | -1.06 Million | -122 Thousand | 38 Thousand | 75 Thousand | 37 Thousand | -782 Thousand |
| Investing Cash Flow | - | - | -341 Thousand | -3.91 Million | -3.62 Million | 782 Thousand |
| Investments in PPE | - | - | -341 Thousand | -3.91 Million | -5.4 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -341 Thousand | -3.91 Million | 1.77 Million | 782 Thousand |
| Financing Cash Flow | -442 Thousand | -678 Thousand | -673 Thousand | -352 Thousand | 526 Thousand | 328.83 Million |
| Debt repayment | -442 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 316 Thousand | 1.18 Million | 361.22 Million |
| Other Financing Activities | -442 Thousand | - | - | -668 Thousand | -657 Thousand | -32.38 Million |
| Accounts receivables | 3.59 Million | 6.03 Million | 962 Thousand | 1.48 Million | -6.93 Million | -87 Thousand |
| Accounts payables | 217 Thousand | -3.25 Million | -1.44 Million | -3.41 Million | 6.71 Million | 392 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -838 Thousand | -11.72 Million | 2.52 Million | -3.32 Million | 2.19 Million | 115 Thousand |
| Cash at beginning of period | 56.59 Million | 116.11 Million | 187.96 Million | 261.1 Million | 349.32 Million | 50.78 Million |
| Cash at end of period | 41.18 Million | 56.59 Million | 116.11 Million | 187.96 Million | 261.1 Million | 349.32 Million |
| Capital Expenditure | - | - | -341 Thousand | -3.91 Million | -5.4 Million | - |
| Effect of forex changes on cash | - | 198 Thousand | -2.52 Million | 8.52 Million | -1.64 Million | - |
| Net cash flow / Change in cash | -15.41 Million | -59.52 Million | -71.84 Million | -73.13 Million | -88.22 Million | 298.53 Million |
| Free Cash Flow | -14.97 Million | -59.04 Million | -68.64 Million | -81.31 Million | -88.87 Million | -31.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.7 Million | -3.7 Million | -4.25 Million | -20.31 Million | -4.25 Million | -5.84 Million |
| Depreciation & Amortization | 74 Thousand | 74 Thousand | 93.5 Thousand | 371 Thousand | 93.5 Thousand | 93 Thousand |
| Deferred income taxes | - | - | - | - | - | -1000.00 |
| Stock-based compensation | 131.5 Thousand | 131.5 Thousand | 323.5 Thousand | 1.95 Million | 323.5 Thousand | 595 Thousand |
| Change in working capital | -1.74 Million | -1.74 Million | 1.65 Million | 2.97 Million | 1.65 Million | -334 Thousand |
| Other non-cash items | 10 Thousand | 10 Thousand | 120.5 Thousand | -1.06 Million | 120.5 Thousand | 12 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -89 Thousand | -89 Thousand | -136 Thousand | -442 Thousand | -136 Thousand | -59 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -89 Thousand | -89 Thousand | -136 Thousand | - | -136 Thousand | - |
| Accounts receivables | - | - | 1.79 Million | 3.59 Million | 1.79 Million | - |
| Accounts payables | - | - | - | 217 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.74 Million | -1.74 Million | -140 Thousand | -838 Thousand | -140 Thousand | - |
| Cash at beginning of period | - | - | 45.57 Million | 56.59 Million | 45.57 Million | 51.12 Million |
| Cash at end of period | -5.32 Million | -5.32 Million | 41.18 Million | 41.18 Million | 43.38 Million | 45.57 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.32 Million | -5.32 Million | -4.39 Million | -15.41 Million | -2.19 Million | -5.54 Million |
| Free Cash Flow | -5.23 Million | -5.23 Million | -2.06 Million | -14.97 Million | -2.06 Million | -5.48 Million |
APLM
IDWM
PTXLF
603393
MEGACPO
ALVET